|
Charles J. Fisher M.D. was elected Director in 2007. He is Chief Medical Officer and Executive Vice President of Clinical and Regulatory Affairs at Cardiome Pharma Corp. He has more than 20 years of leadership experience in clinical research and drug development and during his earlier academic career served as Principal Investigator of numerous clinical trials. Prior to Cardiome Pharma Corp. Dr. Fisher was divisional Vice President of Global Pharmaceutical Development at Abbott Laboratories Limited responsible for the global development of pharmaceuticals biologics and drug coated medical devices. Prior to Abbott Laboratories Limited he was an Executive Director and Clinical Research Fellow at Eli Lilly & Co where he led the scientific team in the development and regulatory approval of Xigris® (drotrecogin alfa (activated)) for the treatment of severe sepsis. Dr. Fisher also held professor and director positions at numerous academic institutions before joining industry including the University of Manitoba the University of California at Davis Medical Center Case Western Reserve University and the Cleveland Clinic Foundation where he was Professor and Head of Critical Care Medicine. | 